Anuj Kalra

Global Business Sector Head - Chronic Disease Management (Diagnostics) at ZEISS Medical Technology

Anuj Kalra is a senior executive at ZEISS with a notable career in finance and operations. He currently holds the position of Head of Business Sector Chronic Disease Management at ZEISS Medical Technology.1 3

Career Progression at ZEISS

Anuj Kalra has had a significant impact on ZEISS's operations in India:

In 2014, he joined ZEISS India and played a crucial role in its transformation process.1
He served as the CFO and COO of ZEISS India, where he was instrumental in strengthening the company's commercial side.1
Effective July 1, 2020, Anuj was promoted to CFO of Carl Zeiss, advancing from his previous role as Head of Finance, Operations and HR at ZEISS India.3

Leadership Style and Achievements

Anuj Kalra is known for his transformative leadership:

He initiated and led a major transformation process at ZEISS India, which gained global recognition.1
His approach involves bringing in new talent, changing existing routines, and implementing new financial control systems.1
Kalra emphasizes the importance of sharing vision and connecting with people to drive organizational change.1

Background and Values

Anuj's leadership style is deeply influenced by his family background and personal values:

He grew up with strong principles of honesty, discipline, and responsibility.1
His career path was shaped by his interest in mathematics and accountancy.1
Kalra's work ethic is characterized by discipline and efficiency, traits he developed early in his career.1

Professional Development

Anuj Kalra continues to engage in professional development and industry leadership:

He has participated in executive education, including a course in Private Equity and Venture Capital from Università Bocconi.2
Kalra is active in sharing his insights at industry events, such as the CONNECT CFO conference.4

Anuj Kalra's career trajectory demonstrates his ability to drive organizational change, his strong financial acumen, and his commitment to continuous learning and development in the medical technology sector.